Up To 50 SAR OFF Your First Order Use Code : APP50 | Get Free Delivery With No Minimum Order

Frequently bought together
PATADAY 0.2% EYE DROPS 2.5ML
- Sku : I-022902
Key features
PATADAY 0.2% Eye Drops is an ophthalmic solution containing olopatadine 0.2% as the active ingredient. It acts as a selective histamine H1 receptor antagonist with mast cell stabilizing properties, inhibiting the release of histamine and other inflammatory mediators to reduce allergic inflammation. It is indicated for the treatment of ocular itching associated with allergic conjunctivitis. Supplied as a 2.5 ml ophthalmic solution.- Brand: PATADAY
- Active Ingredient: OLOPATADINE 0.2%
- Strength: 0.2%
- Dosage Form: Eye drops, solution
- Pack Size: 2.5 ml
- Route: Ocular use
- Prescription Status: Prescription
- Therapeutic Class: Ophthalmic
- Pharmacological Group: Decongestants & Antiallergics (Eye)
- Drug Class: Topical ophthalmic selective H1-antihistamine with mast cell stabilizing properties (dual-acting antiallergic).
- Manufacturer: ALCON LABORATORIES
- Country of Origin: United States
- SFDA Registration No.: 0309258150
- Shelf Life: 24 months
- Storage: store below 30°c
- Target Organ: Eye
- Preservative Free: No
Frequently bought together
Indications
Approved Uses
Treatment of ocular itching associated with allergic conjunctivitis.
Dosage & Administration
Dosing by Condition
Ocular itching associated with allergic conjunctivitis (adults and children ≥2 years): instill 1 drop in each affected eye once daily.
Initial Dose
One drop in the affected eye(s) once daily.
Maintenance Dose
One drop in the affected eye(s) once daily.
Maximum Dose
1 drop in each affected eye once daily (maximum: once daily).
Children's Dosage
Children ≥2 years: 1 drop in each affected eye once daily (same as adult dosing)
Dose Adjustment Notes
No dose adjustment is generally required for renal or hepatic impairment or in the elderly with ophthalmic olopatadine due to minimal systemic exposure.
How to Take
Wash hands. Remove contact lenses. Tilt head back, pull down lower eyelid to form a pocket, instill 1 drop into the affected eye(s) once daily. Close eye gently and apply nasolacrimal occlusion (press inner corner) for 1-2 minutes. Do not touch dropper tip to eye/skin/surfaces. If using other ophthalmic products, separate by at least 5 minutes (ointments last).
Side Effects
Common Side Effects
Common adverse effects include transient eye burning/stinging, blurred vision, dry eye, foreign body sensation, eye hyperemia/redness, and headache; nasopharyngitis/upper-respiratory symptoms can also occur.
Side Effect Frequency
Common (≥1% to <10%): headache; ocular burning/stinging; blurred vision; dry eye; foreign body sensation; ocular hyperemia; eye pruritus. Uncommon/rare: keratitis/corneal disorders; hypersensitivity reactions.
Safety & Warnings
Contraindications
Hypersensitivity to olopatadine or any component of the formulation.
Warnings & Precautions
For ocular use only (not oral/injectable); avoid contamination (do not touch dropper tip); remove contact lenses before use and wait at least 10 minutes before reinsertion; do not wear lenses if eyes are red/irritated; contains benzalkonium chloride which can irritate eyes and discolor soft lenses.
Age Restriction
Not approved/recommended for children under 2 years of age.
Drug Interactions
Interaction Severity
No clinically significant drug interactions are expected with ophthalmic olopatadine at recommended doses; theoretical additive CNS depression with sedatives/alcohol is unlikely due to minimal systemic absorption.
Special Populations
Children
Children ≥2 years: 1 drop in each affected eye once daily (same as adult dosing)
Kidney Impairment
No adjustment needed.
Storage & Patient Advice
Patient Counseling
Use 1 drop in affected eye(s) once daily. Remove contact lenses before use and wait at least 10 minutes before reinserting (and avoid use with contact lenses if eyes are red/irritated). Do not touch the dropper tip; recap after use. Temporary blurred vision may occur-avoid driving until clear. If using other eye meds, separate by ≥5 minutes. Store below 30°C (per SFDA).
Monitoring Requirements
No routine monitoring required.
Pharmacology
Mechanism of Action
A selective histamine H1 antagonist and mast cell stabilizer that inhibits the release of histamine and other inflammatory mediators from mast cells, reducing the signs and symptoms of allergic conjunctivitis.
Onset of Action
Onset is rapid-typically within minutes (about 5-10 minutes) for relief of ocular itching, with effect sustained through the day for once-daily products.
Duration of Effect
Up to 24 hours.
Bioavailability
Low systemic bioavailability after topical ocular administration; plasma concentrations are low (often very low/near quantification limits).
Product Information
Available Dosage Forms
Eye drops, solution (ophthalmic) for this product.
OTC Alternatives
Depending on country/market: ketotifen fumarate 0.025% ophthalmic solution (OTC in many regions) and some olopatadine ophthalmic strengths may be OTC in certain markets; availability varies by local regulation (SFDA lists this product as Prescription).
Target Organ
Eye
Preservative Free
No
Legal Disclaimer - Al Mujtama Pharmacy
The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment.
Al Mujtama Pharmacy assumes no legal or medical liability for:
- Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist
- Any discrepancy between the information provided and the product's package insert or SFDA guidelines
- Any misuse of medication resulting from personal interpretation of the content displayed
Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication.
By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation.
Your health is a trust - always consult your doctor first.
-1744229570.gif)











